Benefits to health from a high consumption of fruits and vegetables are well established and have been attributed to bioactive secondary metabolites present in edible plants. However, the effects of specific health-related phytochemicals within a complex food matrix are difficult to assess. In an attempt to address this problem, we have used elicitation to improve the nutraceutical content of seedlings of Brassica oleracea grown under controlled conditions. Analysis, by LC-MS, of the glucosinolate, isothiocyanate and phenolic compound content of juices obtained from sprouts indicated that elicitation induces an enrichment of several phenolics, particularly of the anthocyanin fraction. To test the biological activity of basal and enriched juices we took advantage of a recently developed in vitro model of inflamed human intestinal epithelium. Both sprouts’ juices protected intestinal barrier integrity in Caco-2 cells exposed to tumor necrosis factor α under marginal zinc deprivation, with the enriched juice showing higher protection. Multivariate regression analysis indicated that the extent of rescue from stress-induced epithelial dysfunction correlated with the composition in bioactive molecules of the juices and, in particular, with a group of phenolic compounds, including several anthocyanins, quercetin-3-Glc, cryptochlorogenic, neochlorogenic and cinnamic acids

Ferruzza, S.; Natella, F.; Ranaldi, G.; Murgia, C.; Rossi, C.; Trost, K.; Mattivi, F.; Nardini, M.; Maldini, M.; Giusti, A.; Moneta, E.; Scaccini, C.; Sambuy, Y.; Morelli, G.; Baima, S. (2016). Nutraceutical improvement increases the protective activity of broccoli sprout juice in a human intestinal cell model of gut inflammation. PHARMACEUTICALS, 9 (48): 1-18. doi: 10.3390/ph9030048 handle: http://hdl.handle.net/10449/34951

Nutraceutical improvement increases the protective activity of broccoli sprout juice in a human intestinal cell model of gut inflammation

Trost, Kajetan;Mattivi, Fulvio;
2016-01-01

Abstract

Benefits to health from a high consumption of fruits and vegetables are well established and have been attributed to bioactive secondary metabolites present in edible plants. However, the effects of specific health-related phytochemicals within a complex food matrix are difficult to assess. In an attempt to address this problem, we have used elicitation to improve the nutraceutical content of seedlings of Brassica oleracea grown under controlled conditions. Analysis, by LC-MS, of the glucosinolate, isothiocyanate and phenolic compound content of juices obtained from sprouts indicated that elicitation induces an enrichment of several phenolics, particularly of the anthocyanin fraction. To test the biological activity of basal and enriched juices we took advantage of a recently developed in vitro model of inflamed human intestinal epithelium. Both sprouts’ juices protected intestinal barrier integrity in Caco-2 cells exposed to tumor necrosis factor α under marginal zinc deprivation, with the enriched juice showing higher protection. Multivariate regression analysis indicated that the extent of rescue from stress-induced epithelial dysfunction correlated with the composition in bioactive molecules of the juices and, in particular, with a group of phenolic compounds, including several anthocyanins, quercetin-3-Glc, cryptochlorogenic, neochlorogenic and cinnamic acids
Functional food
Broccoli sprouts
Caco-2
Intestinal permeability
Inflammatory response
Phenolic compounds
Anthocyanins
Sulforafane
Alimenti funzionali
Germogli di broccoli
Caco-2
Permeabilità intestinale
Risposta infiammatoria
Composti fenolici
Antociani
Sulforafano
Settore CHIM/10 - CHIMICA DEGLI ALIMENTI
2016
Ferruzza, S.; Natella, F.; Ranaldi, G.; Murgia, C.; Rossi, C.; Trost, K.; Mattivi, F.; Nardini, M.; Maldini, M.; Giusti, A.; Moneta, E.; Scaccini, C.; Sambuy, Y.; Morelli, G.; Baima, S. (2016). Nutraceutical improvement increases the protective activity of broccoli sprout juice in a human intestinal cell model of gut inflammation. PHARMACEUTICALS, 9 (48): 1-18. doi: 10.3390/ph9030048 handle: http://hdl.handle.net/10449/34951
File in questo prodotto:
File Dimensione Formato  
Ferruzza_et_al_Pharmaceuticals_2016.pdf

accesso aperto

Descrizione: Main article
Licenza: Creative commons
Dimensione 2.21 MB
Formato Adobe PDF
2.21 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10449/34951
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 12
social impact